BFBIO financials BF Biosciences Limited
BF Biosciences Limited (BFBIO) has 2 financial years on file, from the year to 30 Jun 2025. The latest, the year to 30 Jun 2026 earned Rs 7.16 a share on sales of Rs 9.5 bn. 5 quarters are listed below the years.
Results by financial year
Company accounts as filed. Earnings per share are on today’s share count where a split or bonus issue came later. Years to 30 June. 2 of the last 5 years and 5 of the last 8 quarters.
Earnings per share by financial year
| Year | Earnings per share (Rs) | Sales | Gross margin | Net profit as a share of sales | Change in earnings per share on the year before |
|---|---|---|---|---|---|
| Year to 30 Jun 2026 | 7.16 | Rs 9.5 bn | 43.2% | 6.7% | +29.7% |
| Year to 30 Jun 2025 | 5.52 | Rs 5.8 bn | 39.2% | 7.7% | — |
Results by quarter
5 of the last 8 quarters. The fourth quarter is filed only inside the annual accounts.
| Quarter | Earnings per share (Rs) | Sales | Profit after tax | Net profit as a share of sales | Change on the same quarter a year before |
|---|---|---|---|---|---|
| Quarter to 30 Sep 2026 | 2.09 | Rs 2.8 bn | Rs 184.9 m | 6.6% | +15.5% |
| Quarter to 31 Mar 2026 | 1.33 | Rs 2.1 bn | Rs 117.6 m | 5.5% | -16.4% |
| Quarter to 31 Dec 2025 | 2.13 | Rs 2.7 bn | Rs 187.8 m | 7.0% | — |
| Quarter to 30 Sep 2025 | 1.81 | Rs 2.4 bn | Rs 159.5 m | 6.6% | — |
| Quarter to 31 Mar 2025 | 1.59 | Rs 1.5 bn | Rs 124.5 m | 8.3% | — |
Cash flow
Where the cash came from and went
| Profit after tax | Rs 632.1 m |
| Depreciation and amortisation | Rs 0 thousand |
| Operating cash flow | Rs -26.5 m |
| Capital spending | Rs -603.1 m |
| Free cashworked out: operating cash flow less capital spending | Rs -629.6 m |
| Change in cash | Rs -73.1 m |
| Cash at the start of the year | Rs 322.4 m |
| Cash at the end of the year | Rs 249.3 m |
Accounts, year to 30 Jun 2026 · filed annual report, page 61The report does not say whether these are group accounts or the company’s own.
Debt
Borrowings and cash
Interest covered by operating profit: Rs 1.2 bn against Rs 106.0 m, 11.1 times
Accounts, year to 30 Jun 2026 · filed annual report, page 61The report does not say whether these are group accounts or the company’s own.
More on BFBIO
- BFBIO share price and overview
- Pharmaceuticals sector
- CPHL financials · Citi Pharma Ltd.
- CWHC financials · Crestwell Healthcare Limited
- FEROZ financials · Ferozsons Laboratories Limited
- GLAXO financials · GlaxoSmithKline Pakistan Limited
- ABOT financials · Abbott Laboratories (Pakistan) Limited
- HALEON financials · Haleon Pakistan Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .